Place des antiarthrosiques symptomatiques d'action lente dans l'arthrose (sulfate de chondroïtine, glucosamine, acide hyaluronique) [Role of slow-acting anti-arthritic agents in osteoarthritis (chondroitin sulfate, glucosamine, hyaluronic acid)].

Détails

ID Serval
serval:BIB_9F54B7E7EAC2
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Place des antiarthrosiques symptomatiques d'action lente dans l'arthrose (sulfate de chondroïtine, glucosamine, acide hyaluronique) [Role of slow-acting anti-arthritic agents in osteoarthritis (chondroitin sulfate, glucosamine, hyaluronic acid)].
Périodique
Revue Médicale Suisse
Auteur⸱e⸱s
Aubry-Rozier B.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2012
Volume
8
Numéro
332
Pages
571-576
Langue
français
Notes
Publication types: English Abstract ; Journal Article Publication Status: ppublish
Résumé
Osteoarthritis (OA) is one of the major causes of pain and of outpatient's clinics. 15 years ago, physiopathology of OA and its potential therapeutic targets were announced to be better understood, but the results of therapeutic trials were finally not as convincing as expected. Slow Acting Drugs (SADs) are part of the treatments evaluated in OA. Even if evidence based medicine is low, positive effects of SADs have been observed. We can reasonably propose these treatments for a short test period. It can sometimes enable us to decrease the dosage of others treatment such as NSAIDs. In any case, the physician must properly inform the patient about products available in Switzerland and must be aware of degrees of purity and costs of the products available on the intemet.
Mots-clé
Antirheumatic Agents/administration & dosage, Antirheumatic Agents/adverse effects, Chondroitin Sulfates/therapeutic use, Delayed-Action Preparations, Drug Therapy, Combination, Evidence-Based Medicine, Glucosamine/therapeutic use, Humans, Hyaluronic Acid/therapeutic use, Osteoarthritis/complications, Osteoarthritis/drug therapy, Pain/drug therapy, Pain/etiology, Treatment Outcome, Viscosupplements/therapeutic use
Pubmed
Création de la notice
31/05/2012 18:22
Dernière modification de la notice
20/08/2019 15:05
Données d'usage